Innovation and Research

The Clinical and Translational Science Institute at the University of Pittsburgh has awarded $900,000 to 17 studies to address different aspects of the COVID-19 pandemic.

The Hemolung respiratory assist system, which was designed at the University of Pittsburgh, has been granted emergency use authorization from the FDA to treat lung failure caused by COVID-19.

Pitt psychologist Sophia Choukas-Bradley has developed a scale for gauging body image consciousness, and using it, she’s found that teens think about the way they present to an online audience, even in their offline moments.

Researchers at Pitt and Carnegie Mellon University are finding out how the brain learns new tasks, which could help people who have suffered injuries to the nervous system. Their latest findings were published today in Nature Biomedical Engineering.

PhD candidate Tyler Quinn (EDUC '15) works with the National Institute of Occupational Safety and Health to make sure personal protective equipment doesn't put a strain on the wearer's ability to work.

The Pitt institute is offering free resource guides, webinars and advice on federal and state programs to help small business owners through the pandemic.

From ancient Egyptian war games to Candy Land and Settlers of Catan, Pitt researcher Zachary Horton explains the evolution of board games and why they’re more popular today than ever, just in time for National Board Game Day on April 11.

A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched this week at UPMC to address one of the most important debates during the COVID-19 pandemic: How should doctors decide between quickly adopting new therapies and waiting until they are tested in longer clinical trials?

April 12, 2020, marks 65 years since the polio vaccine, developed by a team led by Pitt’s Jonas Salk, was deemed safe and effective. Its success helped move vaccine science forward.

University of Pittsburgh School of Medicine scientists announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.